Total Payments
$113,994
2024 Payments
$48,086
Companies
4
Transactions
50
Medicare Patients
1,154
Medicare Billing
$304,094
Payment Breakdown by Category
Consulting$112,425 (98.6%)
Travel$1,085 (1.0%)
Food & Beverage$325.74 (0.3%)
Education$157.32 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $112,425 | 12 | 98.6% |
| Travel and Lodging | $1,085 | 2 | 1.0% |
| Food and Beverage | $325.74 | 7 | 0.3% |
| Education | $157.32 | 29 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $109,200 | 10 | $0 (2024) |
| Travere Therapeutics, Inc. | $4,251 | 38 | $0 (2024) |
| AstraZeneca UK Limited | $525.00 | 1 | $0 (2022) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $17.83 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $48,086 | 30 | AstraZeneca Pharmaceuticals LP ($47,950) |
| 2023 | $51,628 | 5 | AstraZeneca Pharmaceuticals LP ($51,625) |
| 2022 | $14,236 | 12 | AstraZeneca Pharmaceuticals LP ($9,625) |
| 2021 | $42.83 | 3 | Travere Therapeutics, Inc. ($25.00) |
All Payment Transactions
50 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/09/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 09/09/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $0.37 | General |
| 09/03/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $0.37 | General |
| 08/30/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 08/23/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $11.77 | General |
| 07/25/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $11.77 | General |
| 07/25/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 07/23/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.38 | General |
| 07/16/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 07/16/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $0.37 | General |
| 06/18/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Consulting Fee | Cash or cash equivalent | $12,075.00 | General |
| Category: Respiratory | ||||||
| 06/18/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 06/18/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 06/18/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $0.37 | General |
| 05/22/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 05/10/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $11.77 | General |
| 05/10/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 05/07/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 05/07/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $0.37 | General |
| 05/01/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 04/19/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 04/15/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 04/12/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Consulting Fee | Cash or cash equivalent | $15,400.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/02/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 03/28/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 212 | 384 | $194,790 | $46,233 |
| 2022 | 7 | 263 | 490 | $240,365 | $58,739 |
| 2021 | 7 | 287 | 651 | $349,300 | $88,787 |
| 2020 | 9 | 392 | 883 | $486,059 | $110,335 |
Total Patients
1,154
Total Services
2,408
Medicare Billing
$304,094
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 20 | 80 | $93,200 | $22,462 | 24.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 37 | 74 | $31,450 | $6,898 | 21.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 40 | 51 | $12,655 | $5,248 | 41.5% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 44 | 92 | $27,600 | $4,882 | 17.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 22 | 36 | $10,620 | $2,231 | 21.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 20 | 21 | $11,865 | $2,036 | 17.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 12 | $3,981 | $1,297 | 32.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 17 | 18 | $3,419 | $1,181 | 34.5% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 22 | 104 | $112,320 | $29,475 | 26.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 59 | 124 | $48,970 | $9,907 | 20.2% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 51 | 95 | $26,590 | $5,354 | 20.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 37 | 48 | $12,329 | $4,330 | 35.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 35 | 37 | $19,230 | $3,930 | 20.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 19 | 23 | $5,612 | $2,408 | 42.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 20 | 37 | $10,170 | $1,863 | 18.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 20 | 22 | $5,144 | $1,473 | 28.6% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 22 | 164 | $173,840 | $46,883 | 27.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 82 | 200 | $78,000 | $16,282 | 20.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 42 | 64 | $15,616 | $6,710 | 43.0% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 52 | 108 | $29,700 | $6,137 | 20.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 21 | 28 | $21,000 | $4,261 | 20.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 32 | 35 | $17,850 | $3,641 | 20.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 19 | 33 | $8,052 | $3,597 | 44.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 17 | 19 | $5,242 | $1,276 | 24.3% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2020 | 43 | 220 | $221,100 | $50,347 | 22.8% |
About Dr. Daniel Gray, MD
Dr. Daniel Gray, MD is a Nephrology healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1295779932.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Gray, MD has received a total of $113,994 in payments from pharmaceutical and medical device companies, with $48,086 received in 2024. These payments were reported across 50 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($112,425).
As a Medicare-enrolled provider, Gray has provided services to 1,154 Medicare beneficiaries, totaling 2,408 services with total Medicare billing of $304,094. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Rochester, NY
- Active Since 06/15/2006
- Last Updated 07/05/2023
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1295779932
Products in Payments
- LOKELMA (Drug) $97,650
- TEZSPIRE (Biological) $12,075
- JYNARQUE (Drug) $17.83
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Rochester
David Bushinsky, Md, MD
Nephrology — Payments: $172,916
Nephrology $172,916
Neera Dahl, Md, MD
Nephrology — Payments: $116,887
Nephrology $116,887
Fernando Fervenza, M.d, M.D
Nephrology — Payments: $87,112
Nephrology $87,112
Robert Mayo, M.d, M.D
Nephrology — Payments: $64,976
Nephrology $64,976
Leslie Wong, Md, MD
Nephrology — Payments: $64,754
Nephrology $64,754
John Lieske, M.d, M.D
Nephrology — Payments: $48,304
Nephrology $48,304